Lactic acid bacteria have been investigated as a suitable means of delivering therapeutic proteins or peptides to mucosal surfaces in the body
Research-Grade vs 503A Compounded: Why the Source Determines the Outcome The BPC-157 before and after results that patients read about online come from a wide range of sources with a wide range of quality
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide), belonging to AngIV-related peptides, is an allosteric activator of HGF and enhances MET signaling in the brain (Yuan et al., 2019), the engineered protein eNK1, created by the disulfide-linked NK1 (N-terminal and the K1 first kringle) domains of HGF (Vallarola et al., 2020), the semi-synthetic engineered K1 domain, designed to be multimer by biotin-avidin interaction (Ueki et al., 2016, 2020), and MET-agonistic synthetic macrocyclic peptides (Vallarola et al., 2020)
Here are two notable trials underlying these potential benefits: In a study involving 107 patients with alcohol (n = 47) or opiate (n = 60) withdrawal symptoms, DSIP was administered intravenously based on the hypothesis of its agonistic activity on opiate receptors
Tirzepatide: FDA approved and widely available Tirzepatide received FDA approval for type 2 diabetes (as Mounjaro) in 2022 and for chronic weight management (as Zepbound) in 2023